Related Experiment Video
Updated: May 30, 2026

Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
Medication safety in neonates
1Institute for Safe Medication Practices, Horsham, Pennsylvania 19044, USA. rdabliz@hotmail.com
Insights
Newborn intensive care units (NICUs) are high-risk environments where medication errors can harm vulnerable infants. Implementing safe medication practices requires collaboration among all healthcare professionals to protect neonates.
Area of Science:
- Neonatal care
- Patient safety
- Medication management
Background:
- Newborn intensive care units (NICUs) are critical care settings for vulnerable infants.
- The NICU environment poses risks for medication errors, potentially causing severe harm or death.
- Safe medication practices are essential for improving outcomes in neonates.
Purpose of the Study:
- To highlight significant areas of concern regarding medication use in NICUs.
- To emphasize the need for a collaborative approach to medication safety.
- To provide recommendations for a safe and efficient medication use system in NICUs.
Main Methods:
- Recommendations organized according to the Institute for Safe Medication Practices' Key Elements of the Medication Use System™.
- Focus on significant areas of concern within the NICU medication use process.
- Involves participation of all individuals in the medication use process.
Main Results:
- Identified NICUs as high-risk areas for medication errors.
- Stressed the critical role of all healthcare professionals in medication safety.
- Highlighted the importance of administrative and organizational leadership support.
Conclusions:
- All individuals involved in neonatal care are responsible partners in ensuring medication safety.
- A safe and efficient medication use system requires active participation in its design and sustainment.
- Promoting safe medication practices is crucial for the well-being of neonates in the NICU.
Abstract:
Newborn intensive care units (NICUs) are high-risk areas of care, where complex medical interventions are performed, and are recognized as a resource for improved outcome in premature and low-birth-weight infants or those presenting with acute conditions. This critical environment, along with the vulnerable nature of the population it serves, places patients at risk for medication errors, which can result in permanent harm or death. Promoting safe medication practices requires participation of all individuals involved in the medication use process (e.g., physicians, nurses, nurse practitioners, physician assistants, pharmacists, respiratory therapists, pharmacy technicians). The following recommendations, organized in accordance with the Institute for Safe Medication Practices' Key Elements of the Medication Use System™, will focus on significant areas of concern within the NICU. All individuals caring for neonates, supported by administrators and organizational leaders, should recognize themselves as active partners responsible for the safety of this fragile patient population by participating in the design and sustainment of a safe and efficient medication use system.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Factors Affecting Drug Response: Overview

